Ragweed Observational Study

Ragweed Allergy Clinical Trial

Official title:
An Observational Multi-Centre Field Study to Assess Symptom Scores and Rescue Medication Usage in Subjects With a History of Ragweed Allergen-Induced Rhinoconjunctivitis

Status Completed

Clinical Trial Summary

This is an observational to evaluate Total Rhinoconjunctivitis Symptom Score and rescue medication usage (as measured by Rescue Medication Score as a Combined Score to inform the design of a phase III field study with ToleroMune Ragweed.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Ragweed Allergy

Clinical Trial Details

NCT number	NCT01398137
Study type	Observational
Source	Circassia Limited
Contact
Status	Completed
Phase	N/A
Start date	July 2011
Completion date	October 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01198613` - ToleroMune Ragweed Exposure Chamber Study	Phase 2
Recruiting	`NCT05346718` - Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis	N/A
Completed	`NCT01448603` - ToleroMune Ragweed Follow up Study	N/A
Completed	`NCT01361412` - Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy	Phase 2
Completed	`NCT02396680` - Ragweed-SPIRE Follow-On Study	N/A